You just read:

Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura

News provided by

Amgen

Nov 10, 2017, 06:29 ET